Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

BACKGROUND: The mainstay of control of the coronavirus disease 2019 (Covid-19) pandemic is vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Within a year, several vaccines have been developed and millions of doses delivered. Reporting of adverse events is a critical...

Descripción completa

Detalles Bibliográficos
Autores principales: Scully, Marie, Singh, Deepak, Lown, Robert, Poles, Anthony, Solomon, Tom, Levi, Marcel, Goldblatt, David, Kotoucek, Pavel, Thomas, William, Lester, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112532/
https://www.ncbi.nlm.nih.gov/pubmed/33861525
http://dx.doi.org/10.1056/NEJMoa2105385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112532/
https://www.ncbi.nlm.nih.gov/pubmed/33861525
http://dx.doi.org/10.1056/NEJMoa2105385

Ejemplares similares